1. Home
  2. NTRA vs AER Comparison

NTRA vs AER Comparison

Compare NTRA & AER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • AER
  • Stock Information
  • Founded
  • NTRA 2003
  • AER 1995
  • Country
  • NTRA United States
  • AER Ireland
  • Employees
  • NTRA N/A
  • AER N/A
  • Industry
  • NTRA Medical Specialities
  • AER Diversified Commercial Services
  • Sector
  • NTRA Health Care
  • AER Consumer Discretionary
  • Exchange
  • NTRA Nasdaq
  • AER Nasdaq
  • Market Cap
  • NTRA 27.0B
  • AER 21.6B
  • IPO Year
  • NTRA 2015
  • AER 2006
  • Fundamental
  • Price
  • NTRA $199.57
  • AER $132.91
  • Analyst Decision
  • NTRA Strong Buy
  • AER Strong Buy
  • Analyst Count
  • NTRA 18
  • AER 7
  • Target Price
  • NTRA $208.94
  • AER $133.00
  • AVG Volume (30 Days)
  • NTRA 1.3M
  • AER 1.3M
  • Earning Date
  • NTRA 11-06-2025
  • AER 10-29-2025
  • Dividend Yield
  • NTRA N/A
  • AER 0.81%
  • EPS Growth
  • NTRA N/A
  • AER 63.90
  • EPS
  • NTRA N/A
  • AER 20.89
  • Revenue
  • NTRA $2,116,676,000.00
  • AER $8,344,637,000.00
  • Revenue This Year
  • NTRA $25.70
  • AER $4.02
  • Revenue Next Year
  • NTRA $15.42
  • AER N/A
  • P/E Ratio
  • NTRA N/A
  • AER $6.37
  • Revenue Growth
  • NTRA 38.17
  • AER 6.67
  • 52 Week Low
  • NTRA $125.38
  • AER $85.57
  • 52 Week High
  • NTRA $203.23
  • AER $135.01
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 69.72
  • AER 69.68
  • Support Level
  • NTRA $193.29
  • AER $129.95
  • Resistance Level
  • NTRA $203.23
  • AER $135.01
  • Average True Range (ATR)
  • NTRA 7.37
  • AER 2.50
  • MACD
  • NTRA 0.25
  • AER 0.98
  • Stochastic Oscillator
  • NTRA 80.29
  • AER 86.32

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About AER AerCap Holdings N.V.

AerCap Holdings NV is an aircraft leasing company. Its activities include leasing, financing, sales, and management of commercial aircraft and engines. It also provides aircraft asset management and corporate services to securitization vehicles, joint ventures, and other third parties.It has one business segment: leasing, financing, sales and management of commercial flight equipment (Commercial Flight Equipment Segment).Through its subsidiary, the group also provides engine leasing, certified aircraft engines, airframes, and engine parts. Its geographical segments include United Kingdom, United States, and Other countries.

Share on Social Networks: